Zobrazeno 1 - 10
of 1 691
pro vyhledávání: '"bioresorbable scaffold"'
Autor:
Ya-Nan Gao, Hong-Tao Yang, Zi-Feng Qiu, Feng Qi, Qian-Hong Lu, Jian-Feng Zheng, Zi-Wei Xi, Xin Wang, Li Li, Gui Zhang, De-Yuan Zhang, Yu-Die Lu, Hai-Ping Qi, Hong Qiu, Run-Lin Gao, Yu-Feng Zheng
Publikováno v:
Bioactive Materials, Vol 39, Iss , Pp 135-146 (2024)
Iron is considered as an attractive alternative material for bioresorbable scaffolds (BRS). The sirolimus eluting iron bioresorbable scaffold (IBS), developed by Biotyx Medical (Shenzhen, China), is the only iron-based BRS with an ultrathin-wall desi
Externí odkaz:
https://doaj.org/article/f62a9a8a4bae4e0b86a2d5719dadc884
Autor:
Adrian Włodarczak, Piotr Rola, Szymon Włodarczak, Marek Szudrowicz, Joanna Jaroszewska-Pozorska, Mateusz Barycki, Łukasz Furtan, Michalina Kędzierska, Adrian Doroszko, Maciej Lesiak
Publikováno v:
Advances in Interventional Cardiology, Vol 20, Iss 1, Pp 67-75 (2024)
Externí odkaz:
https://doaj.org/article/ef9247ed001244d8aa01ffa1c08f5b50
Autor:
Akshyaya Pradhan, Shubhajeet Roy, Monika Bhandari, Pravesh Vishwakarma, Marco Alfonso Perrone, Rishi Sethi, Md. Al Hasibuzzaman
Publikováno v:
Clinical Case Reports, Vol 12, Iss 6, Pp n/a-n/a (2024)
Abstract Bioresorbable stents represent a revolutionary treatment for coronary artery disease. Such a device offers the prospect for complete naturalization of artery lumen after strut resorption and restoration of vasomotion while curtailing the dur
Externí odkaz:
https://doaj.org/article/59f6c373b246463a8032776d57173623
Publikováno v:
Indian Heart Journal, Vol 75, Iss 6, Pp 473-476 (2023)
Background: In order to advocate further research in bioresorbable scaffold (BVS) technology we report the final 5-year outcomes of the COBRA II study, the only randomized controlled trial (RCT) performed to investigate the safety, feasibility, and p
Externí odkaz:
https://doaj.org/article/e294759024f3444fa98cc67d9c0c00e2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Anatolian Journal of Cardiology, Vol 27, Iss 7, Pp 408-416 (2023)
Background: This study aimed to assess the relationship between stent parameters and platelet function, as well as the platelet reactivity profiles over time in patients treated with the Xinsorb scaffold. Methods: Adenosine diphosphate-induced maxim
Externí odkaz:
https://doaj.org/article/404c03fb6d5140728c92f113ebfa8947
Autor:
Lili Tan, Xiangxiu Wang, Kungshan Yuan, Tieying Yin, Ruolin Du, Li Shen, Zhirong Zhu, Suhua Yu, Haijun Zhang, Guixue Wang
Publikováno v:
Bioactive Materials, Vol 23, Iss , Pp 170-186 (2023)
Purpose: This review aims to explore the history, research hotspots, and emerging trends of drug-eluting stents(DES)in the last two decades from the perspective of structural and temporal dynamics. Methods: Publications on DES were retrieved from WoS
Externí odkaz:
https://doaj.org/article/1464c31dac90492aa1b36d1a88422a63
Bioresorbable Scaffolds for Below-the-Knee Arterial Disease: A Literature Review of New Developments
Autor:
Hong-Jie Cui, Ying-Feng Wu
Publikováno v:
Reviews in Cardiovascular Medicine, Vol 25, Iss 4, p 133 (2024)
This review aimed to explore the therapeutic effect of bioabsorbable stents in the inferior genicular artery, from the emergence of absorbable bare metal stents to the latest technology in polymer and anti-proliferative eluting drugs mixed with coate
Externí odkaz:
https://doaj.org/article/8e7a29b75cf64385ae91a2c1c617aad1
Autor:
Juncen Zhou, Elias Georgas, Yingchao Su, Jiayi Zhou, Nadja Kröger, Felix Benn, Alexander Kopp, Yi‐Xian Qin, Donghui Zhu
Publikováno v:
Advanced Science, Vol 10, Iss 26, Pp n/a-n/a (2023)
Abstract Additively manufactured scaffolds offer significant potential for treating bone defects, owing to their porous, customizable architecture and functionalization capabilities. Although various biomaterials have been investigated, metals – th
Externí odkaz:
https://doaj.org/article/9b7bd7a63c294e9f9871b8278d9f475e
Publikováno v:
Trials, Vol 24, Iss 1, Pp 1-10 (2023)
Abstract Background Dual antiplatelet therapy (DAPT) with aspirin and a P2Y12 inhibitor is the standard of care after coronary stenting, including coronary stenting involving bioresorbable scaffolds (BRSs). Current clinical guidelines recommend at le
Externí odkaz:
https://doaj.org/article/541db5a133a943818b1d42e05782e750